DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Elisei R, Viola D, Torregrossa L, Giannini R, Romei C, Ugolini C, Molinaro E, Agate L, Biagini A, Lupi C, Valerio L, Materazzi G, Miccoli P, Piaggi P, Pinchera A, Vitti P, Basolo F.
The BRAF(V600E) mutation is an independent, poor prognostic factor for the outcome of patients with low-risk intrathyroid papillary thyroid carcinoma: single-institution results from a large cohort study.
J Clin Endocrinol Metab 2012;
97: 4390-4398
We do not assume any responsibility for the contents of the web pages of other providers.